MegaNano BioTech has exclusively licensed the dendritic vaccine platform
developed by Dr. Chuanhai Cao which has the following novelties:
– Using healthy donor’s blood instead of patient’s blood to generate the
therapeutic vaccine
– Using immature dendritic cell to generate the vaccine other than
matured dendritic cells vaccine
– Using killed and lyophilized antigen sensitized dendritic cell as vaccine to
open this cell-based treatment available to patients around the world
– This therapeutic vaccine applies to any antigen related diseases. It has
been tested for AD and PD treatment and is under testing for lung
cancer, malaria